| Hans-Günter Meyer-Thompson | Verschiedenes
Liver Disease and Fibrosis Assessment in Substance Use-Related Disorders.
Liver Disease and Fibrosis Assessment in Substance Use-Related Disorders.
Zeremski M, Martinez A.
Clin Pharmacol Drug Dev. 2017 Mar;6(2):164-168. doi: 10.1002/cpdd.312.
Abstract